A new and rapid approach for detecting COVID‐19 based on S1 protein fragments

H Li, Z Liu, Y He, Y Qi, J Chen, Y Ma… - Clinical and …, 2020 - Wiley Online Library
The pandemic of novel coronavirus disease 2019 (COVID‐19) seriously threatened the
public health all over the world. A colloidal gold immunochromatography assay for IgM/IgG …

A high-throughput assay for circulating antibodies directed against the S protein of severe acute respiratory syndrome coronavirus 2

S Weiss, J Klingler, C Hioe, F Amanat… - The Journal of …, 2020 - academic.oup.com
More than 24 million infections with the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) were confirmed globally by September 2020. While polymerase chain …

Recombinant protein expression and purification of N, S1, and RBD of SARS-CoV-2 from mammalian cells and their potential applications

J Garcia-Cordero, J Mendoza-Ramirez… - Diagnostics, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has reached an unprecedented level.
There is a strong demand for diagnostic and serological supplies worldwide, making it …

Development of patient-derived human monoclonal antibodies against nucleocapsid protein of severe acute respiratory syndrome coronavirus 2 for coronavirus …

L Zhang, B Zheng, X Gao, L Zhang, H Pan… - Frontiers in …, 2020 - frontiersin.org
The pandemic caused by emerging Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) presents a global public health threat. Illustrating human antibody …

Development and evaluation of a serological test for diagnosis of COVID-19 with selected recombinant spike proteins

P Zhang, Q Gao, T Wang, Y Ke, F Mo, R Jia… - European Journal of …, 2021 - Springer
Serological test is a valuable diagnostic tool for coronavirus disease 2019 (COVID-19).
However, considerable improvements to these tests are needed, especially in the detection …

Evaluation of serum IgM and IgG antibodies in COVID‐19 patients by enzyme linked immunosorbent assay

C Zhou, G Bu, Y Sun, C Ren, M Qu… - Journal of medical …, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is sweeping the world
since the end of 2019. The titer change of antibodies against SARS‐CoV‐2 needs to be …

[PDF][PDF] Serological assays for SARS-CoV-2 infectious disease: benefits, limitations and perspectives

M Infantino, A Damiani, FL Gobbi, V Grossi… - Israel Medical …, 2020 - air.uniud.it
C oronavirus disease 2019 (COVID-19) is an infectious dis-ease caused by severe acute
respiratory syndrome corona-virus 2 (SARS-CoV-2), which first appeared in Wuhan, China …

Epitope mapping of severe acute respiratory syndrome-related coronavirus nucleocapsid protein with a rabbit monoclonal antibody

X Tian, C Mo, L Zhou, Y Yang, Z Zhou, A You, Y Fan… - Virus research, 2021 - Elsevier
Abstract The emergency SARS-CoV-2, a member of severe acute respiratory syndrome-
related coronaviruses (SARSr-CoV), is still greatly harming the health of mankind. SARS …

Sensitive and specific serological ELISA for the detection of SARS-CoV-2 infections

J Luo, A Brakel, A Krizsan, T Ludwig, M Mötzing… - Virology journal, 2022 - Springer
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
triggered the worldwide coronavirus disease 2019 (COVID-19) pandemic. Serological …

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

L Grzelak, S Temmam, C Planchais… - Science translational …, 2020 - science.org
It is of paramount importance to evaluate the prevalence of both asymptomatic and
symptomatic cases of SARS-CoV-2 infection and their differing antibody response profiles …